Written Question·Department of Health and Social Care·UIN 115271

Idiopathic Pulmonary Fibrosis: Drugs

Tabled: 23 February 2026
Answered: 2 March 2026
Named Day

Question

Michael Wheeler

LabourWorsley and Eccles

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 February 2026 to Question 110592, whether his Department has made an estimate of the earliest date nerandomilist could become available to patients after NICE publishes

Answer

Dr Zubir Ahmed
Subject to licensing, the National Institute for Health and Care Excellence (NICE) currently expects to publish final guidance on nerandomilast in September 2026. In formulating its recommendations, NICE's independent Appraisal Committee expects to hold i...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 115271) →